Processed pseudogene from the von Hippel-Lindau disease gene is located on human chromosome 1

Diagnostic Molecular Pathology

Volumn 8, Issue 2, 1999, Pages 101-106

  Bradley, John F ^a   Rothberg, Paul G ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

DNA diagnosis; Gene mapping; Pseudogene; Tumor suppressor; VHL gene; von Hippel Lindau disease

Indexed keywords

ARTICLE; CHROMOSOME 1; DNA TEMPLATE; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; GENE SEQUENCE; HUMAN; INTRON; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOGENE; STOP CODON; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LIGASES; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEINS; PSEUDOGENES; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0032803222     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199906000-00007     Document Type: Article

References (28)

1. Bradley JF,Baker D, Schwartz ID, Rothberg PG. The importance of heteroduplexes in interpreting the results of PCR-RED diagnostic assays: application to the analysis of mutations in the steroid 21-hydroxylase gene in a case of congenital adrenal hyperplasia. Mol Diag 1998;3:119-24.
2. Chen F, Kishida T, Yao M, et al. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mut 1995;5:66-75.
3. Corless CL, Kibel AS, Iliopoulos O, Kaelin WG, Jr. Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues. Hum Pathol 1997;28:459-64.
4. Crossey PA, Richards FM, Foster K, et al. Identification of intragenic mutations in the Von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 1994;3:1303-8.
5. Czosnek HH, Bienz B, Givol D, Zakut-Houri R, Pravtcheva DD, Ruddle RH, Oren M. The gene and the pseudogene for mouse p53 cellular tumor antigen are located on different chromosomes. Mol Cell Biol 1984;4:1638-40.
6. Duan DR, Pause A, Burgess WH, et al. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 1995; 269:1402-6.
7. Glavac D, Neumann HPH, Wittke C, et al. Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum Genet 1996;98: 271-80.
8. Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet 1994;7:85-90.
9. Gnarra JR, Zhou S, Merrill MJ, et al. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA 1996; 93:10589-94.
10. Gyapay G, Schmitt K, Fizames C, et al. A radiation hybrid map of the human genome. Hum Mol Genet 1996;5:339-46.
11. Herold KM, Rothberg PG. Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. Oncogene 1988;3:423-8.
12. Iliopoulos O, Levy A, Jiang C, Kaelin WG Jr, Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 1996;93:10595-9.
13. Iliopoulos O, Ohh M, Kaelin WG, Jr. pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc Natl Acad Sci USA 1998;95:11661-6.
14. Kaelin WG, Maher ER. The VHL tumour-suppressor gene paradigm. Trend Genet 1998;14:423-6.
15. Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG, Jr. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 1995;269:1444-6.
16. Knudson AG Jr. Mutation and cancer: statistical study of retino-blastoma. Proc Natl Acad Sci USA 1971;68:820-3.
17. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
18. Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ, Moore AT. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet 1996;33:328-32.
19. Pause A, Lee S, Worrell RA, Chen DYT, Burgess WH, Linehan WM, Klausner RD. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 1997;94: 2156-61.
20. Renbaum P, Duh F-M, Latif F, Zbar B, Lerman MI, Kuzmin I. Isolation and characterization of the full-length 3′ untranslated region of the human von Hippel-Lindau tumor suppressor gene. Hum Genet 1996;98:666-71.
21. Richards FM, Schofield PN, Fleming S, Maher ER. Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis. Hum Mol Genet 1996;5:639-44.
22. Rothberg PG, Ponnuru S, Baker D, et al. A deletion polymorphism due to Alu-Alu recombination in intron 2 of the retinoblastoma gene: association with human gliomas. Mol Carcinogen 1997;19: 69-73.
23. Schoenfeld A, Davidowitz EJ, Burk RD. A second major native von Hippel-Lindau gene product, intitiated from an internal translation start site, functions as a tumor suppressor. Proc Natl Acad Sci USA 1998;95:8817-22.
24. Shuin T, Kondo K, Torigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994;54:2852-5.
25. Tanooka H, Ootsuyama A, Sasaki H. Homologous recombination between p53 and its pseudogene in a radiation-induced mouse tumor. Cancer Res 1998;58:5649-51.
26. Whaley JM, Naglich J, Gelbert L, et al. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 1994;55:1092-102.
27. White PC, Vitek A, DuPont B, New MI. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 1988;85:4436-40.
28. Zbar B, Kishida T, Chen F, et al. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mut 1996;8:348-57.